Bortezomib combined with histone deacetylase inhibitor ITF2357 or arsenic trioxide exerts aynergistic anti-proliferative and pro-apoptotic effect on P39 cells

Copy For Citation

Savli H., Galimberti S., Canestraro M., Nagy B., Palumbo G. A., Petrini M.

JOURNAL OF CLINICAL ONCOLOGY, vol.26, no.15, 2008 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 26 Issue: 15
• Publication Date: 2008
• Doi Number: 10.1200/jco.2008.26.15_suppl.18022
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Kocaeli University Affiliated: No